Curium acquired IASON in June of 2021, further expanding its footprint in Europe for its
What we do
Trusted to make a difference for patients
We develop, manufacture and distribute radiopharmaceutical products that meet industry-leading standards in quality, efficacy and innovation. We specialize in the production and supply of radioactive tracers used in nuclear medicine. By working to enable accurate early diagnosis and treatment of cancer as well as heart, brain and bone diseases, our world-class products empower our customers with effective treatment and proven patient outcomes.
We believe in building long-term partnerships that drive sustainable growth for our customers.
How do we do this?
By providing exceptional service reliability
By maintaining strict quality standards
By constantly innovating and expanding our product portfolio
By putting the lives of patients at the forefront of all we do
By continually improving our business, we help our partners to do the same. In turn, we improve the lives and health outcomes of our patients, ensuring a brighter future for all.
Our future in nuclear medicine includes new imaging modalities, expansion into new territories, new therapies and groundbreaking new approaches to neuroendocrine tumors and prostate cancer. We will also leverage the power of artificial intelligence to improve image quality and accuracy; to identify patterns to help diagnose pathologies; and of course to better support physicians and nuclear medicine and pharmacy health care professionals. This is just the beginning.
The time has come to redefine the experience of cancer. To chart a new path for millions of patients around the world. To provide the necessary nuclear diagnostics and therapies that allow for better lives every day. We achieve this with an honest and transparent approach to the way we conduct business, giving our clients peace of mind and a service they can depend on.
We are wholly dedicated to the nuclear medicine industry, working closely with our clinicians and suppliers to stay ahead of trends and deliver effective radiopharmaceutical solutions. We are striving to improve the quality of care and health outcomes through diagnostics and treatment.
Nuclear medicine is a branch of medicine that uses small amounts of radioactive isotopes to help diagnose, determine the severity of, or treat a variety of diseases, including certain types of cancers, heart disease, gastrointestinal, endocrine, neurological disorders and other abnormalities within the body. Because diagnostic nuclear medicine procedures are able to help visualize molecular activity within the body, they offer the potential to identify disease in its earliest stage, often before symptoms occur or before abnormalities can be detected with other diagnostic tests and can even help identify a patient’s response to therapeutic interventions. Larger amounts of radioactive isotopes can also be used for therapy for certain types of diseases.
Nuclear medicine diagnostic scans can offer unique information, including details on both the function and anatomic structure of the body and have high sensitivity and specificity for cardiology and oncology.
Diagnostic nuclear medicine procedures are non-invasive medical tests that have been used for over 50 years. Depending on the type of nuclear medicine exam, the radiotracer is injected, inhaled, absorbed, or swallowed and accumulates in the organ or area of the body being examined. The isotope then emits radiation from the targeted organ or cell receptor to an external detector, often called a nuclear medicine camera.